Clinical Trial Update: Effect of Phosphate Binders on Markers of Vascular Health in Chronic Kidney Disease Stages 3 and 4 [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating the effects of phosphate binders on vascular health markers in chronic kidney disease patients (stages 3 and 4) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• phosphate binders

Snippet

Sponsor: Albany College of Pharmacy and Health Sciences | Conditions: Chronic Kidney Disease | Phase 4 | Status: TERMINATED